Bio-Rad Laboratories

Traded on the St. Petersburg Stock Exchange
Bio-Rad Laboratories is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. It was founded in 1952 and is headquartered in Hercules, California.
Bio-Rad Laboratories stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Bio-Rad Laboratories balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Bio-Rad Laboratories cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Bio-Rad Laboratories multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Bio-Rad Laboratories profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Bio-Rad Laboratories assets
Bio-Rad Laboratories cash flows

Bio-Rad Laboratories dividend policy

The company doesn't provide dividends

Bio-Rad Laboratories shares

TickerNameTypeNominal valueISINPrice
BIO:USBio-Rad Laboratories, Inc.Common share-US0905722072$350.5
Bio-Rad Laboratories news
29.04.2022
Bio-Rad Laboratories' GAAP loss for 3 months of 2022 was $3.37 million, compared to a profit of $0.977 million in the previous year. Revenue decreased 3.7% to $700.062 million from $726.796 million a year earlier.
Source: investors.bio-rad.com
Pictogram next
11.02.2022
Bio-Rad Laboratories' GAAP net income for 2021 was $4.246 billion, up 11.6% from $3.806 billion in the previous year. Revenue increased 14.8% to $2.923 billion from $2.546 billion a year earlier.
Source: {source} pictogram bio-rad.com
Pictogram next
29.10.2021
Bio-Rad Laboratories' GAAP net income for 9M 2021 was $5.82 billion, up 96.2% from $2.967 billion in the previous year. Revenue increased 24.7% to $2.19 billion from $1.756 billion a year earlier.
Source: {source} pictogram bio-rad.com
Pictogram next
30.07.2021
Bio-Rad Laboratories' GAAP net income for 6 months of 2021 was $1.892 billion, up 14.5% from $1.652 billion in the previous year. Revenue increased 30.1% to $1.443 billion from $1.109 billion a year earlier.
Source: {source} pictogram bio-rad.com
Pictogram next
All Bio-Rad Laboratories news
General information
Company nameBio-Rad Laboratories
Tags#medtech, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services
Business address1000 ALFRED NOBEL DRIVE HERCULES CA 94547 5107247000
Mailing address1000 ALFRED NOBEL DRIVE HERCULES CA 94547
Websitewww.bio-rad.com
Information disclosurewww.sec.gov